CoChat

Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle

Open access

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Accumulating evidence from animal studies suggest that chronic elevation of circulating intestinal-generated lipopolysaccharide (LPS) (i.e., metabolic endotoxemia) could play a role in the pathogenesis of insulin resistance. However, the effect of LPS in human muscle is unclear. Moreover, it is unknown whether blockade/down regulation of toll-like receptor (TLR)4 can prevent the effect of LPS on insulin action and glucose metabolism in human muscle cells. In the present study we compared plasma LPS concentration in insulin resistant [obese non-diabetic and obese type 2 diabetic (T2DM)] subjects versus lean individuals. In addition, we employed a primary human skeletal muscle cell culture system to investigate the effect of LPS on glucose metabolism and whether these effects are mediated via TLR4. Obese non-diabetic and T2DM subjects had significantly elevated plasma LPS and LPS binding protein (LBP) concentrations. Plasma LPS (r = -0.46, P = 0.005) and LBP (r = -0.49, P = 0.005) concentrations negatively correlated with muscle insulin sensitivity (M). In human myotubes, LPS increased JNK phosphorylation and MCP-1 and IL-6 gene expression. This inflammatory response led to reduced insulin-stimulated IRS-1, Akt and AS160 phosphorylation and impaired glucose transport. Both pharmacologic blockade of TLR4 with TAK-242, and TLR4 gene silencing, suppressed the inflammatory response and insulin resistance caused by LPS in human muscle cells. Taken together, these findings suggest that elevations in plasma LPS concentration found in obese and T2DM subjects could play a role in the pathogenesis of insulin resistance and that antagonists of TLR4 may improve insulin action in these individuals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0063983

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Plasma LPS, LBP and sCD14 levels in insulin resistant subjects. Plasma LPS (A), LBP (B) and sCD14 (C) concentrations were determined as described under ‘materials and methods’. All values are the mean ± SEM of data obtained from 12 lean, 9 obese and 10 T2DM subjects. *P<0.05 compared to lean controls.
Figure 1 Plasma LPS, LBP and sCD14 levels in insulin resistant subjects. Plasma LPS (A), LBP (B) and sCD14 (C) concentrations were determined as described under ‘materials and methods’. All values are the mean ± SEM of data obtained from 12 lean, 9 obese and 10 T2DM subjects. *P<0.05 compared to lean controls.CC BY · PubMed Central
Figure 2 LPS induces inflammation and inhibits insulin signaling in human myotubes in a time-dependent manner. Human myotubes were either left untreated or treated with 100 ng/ml LPS for a varying length of time. The time course of IκBα protein degradation (A), JNK phosphorylation (B), and insulin-stimulated IRS-1-tyr612 (E), Akt (F), and AS160 (G) phosphorylation following LPS treatment was determined by Western blotting. The time course of MCP-1 (C) and IL-6 (D) mRNA expression following LPS treatment was determined by quantitative real time PCR. All values are the mean ± SD of triplicates. *P<0.05; #P<0.05 compared to basal.
Figure 2 LPS induces inflammation and inhibits insulin signaling in human myotubes in a time-dependent manner. Human myotubes were either left untreated or treated with 100 ng/ml LPS for a varying length of time. The time course of IκBα protein degradation (A), JNK phosphorylation (B), and insulin-stimulated IRS-1-tyr612 (E), Akt (F), and AS160 (G) phosphorylation following LPS treatment was determined by Western blotting. The time course of MCP-1 (C) and IL-6 (D) mRNA expression following LPS treatment was determined by quantitative real time PCR. All values are the mean ± SD of triplicates. *P<0.05; #P<0.05 compared to basal.CC BY · PubMed Central
Figure 3 TAK-242 prevents LPS-induced inflammation and insulin resistance in human myotubes. Human myotubes were either left untreated or treated with 100 ng/ml LPS for 12 h. Prior to LPS exposure, cells were pre-treated with 1 µM TAK-242 or vehicle control for 1h. JNK phosphorylation (A), insulin-stimulated IRS-1-tyr612 (E), Akt (F), and AS160 (G) phosphorylation were determined by Western blotting. MCP-1 (B) and IL-6 (C) mRNA expression was determined by real time PCR. Glucose transport (D) was determined by measuring 3H-2-DG uptake. The absolute basal glucose transport rates were 43.2±3.2, 46.4±4.1, 46.7±5.6 and 46.5±6.8 pmol/mg,min in cells without LPS, cells with LPS, TAK-242-pretreated cells without LPS, and TAK-242-pretreated cells with LPS, respectively. Results for glucose transport are expressed as the mean ± SEM of data obtained from 5 subjects. All the rest of the values are the mean ± SD of triplicate determinations. Similar experiments were repeated 4 times using cells isolated from different subjects, and representative results are shown. *P<0.05; #P<0.05 compared to basal.
Figure 3 TAK-242 prevents LPS-induced inflammation and insulin resistance in human myotubes. Human myotubes were either left untreated or treated with 100 ng/ml LPS for 12 h. Prior to LPS exposure, cells were pre-treated with 1 µM TAK-242 or vehicle control for 1h. JNK phosphorylation (A), insulin-stimulated IRS-1-tyr612 (E), Akt (F), and AS160 (G) phosphorylation were determined by Western blotting. MCP-1 (B) and IL-6 (C) mRNA expression was determined by real time PCR. Glucose transport (D) was determined by measuring 3H-2-DG uptake. The absolute basal glucose transport rates were 43.2±3.2, 46.4±4.1, 46.7±5.6 and 46.5±6.8 pmol/mg,min in cells without LPS, cells with LPS, TAK-242-pretreated cells without LPS, and TAK-242-pretreated cells with LPS, respectively. Results for glucose transport are expressed as the mean ± SEM of data obtained from 5 subjects. All the rest of the values are the mean ± SD of triplicate determinations. Similar experiments were repeated 4 times using cells isolated from different subjects, and representative results are shown. *P<0.05; #P<0.05 compared to basal.CC BY · PubMed Central
Figure 4 TLR4 silencing protects against LPS-induced inflammation and insulin resistance in human myotubes. Cells were transfected with TLR4 siRNA and negative control siRNA as described under ‘materials and methods’. TLR4 mRNA (A) and protein content (B) were determined by quantitative real time PCR and Western blotting, respectively. Transfected myotubes were either left untreated or treated with 100 ng/ml LPS for 12 h. Glucose uptake (C), JNK phosphorylation (D), and MCP-1 (E) and IL-6 (F) mRNA expression was determined as described above. The absolute basal glucose uptake rates were 30.1±3.2, 35.4±3.9, 30.0±2.1, and 30.7±1.7 pmol/mg,min in the negative control siRNA transfected cells without LPS, negative control siRNA transfected cells with LPS, TLR4 siRNA transfected cells without LPS and TLR4 siRNA transfected cells with LPS, respectively. Results for glucose uptake are expressed as the mean ± SEM of data obtained from 4 subjects. Other values are the mean ± SD of triplicate determinations. Similar experiments were repeated 4 times using cells isolated from different subjects, and representative results are shown. *P<0.05; #P<0.05 compared to basal.
Figure 4 TLR4 silencing protects against LPS-induced inflammation and insulin resistance in human myotubes. Cells were transfected with TLR4 siRNA and negative control siRNA as described under ‘materials and methods’. TLR4 mRNA (A) and protein content (B) were determined by quantitative real time PCR and Western blotting, respectively. Transfected myotubes were either left untreated or treated with 100 ng/ml LPS for 12 h. Glucose uptake (C), JNK phosphorylation (D), and MCP-1 (E) and IL-6 (F) mRNA expression was determined as described above. The absolute basal glucose uptake rates were 30.1±3.2, 35.4±3.9, 30.0±2.1, and 30.7±1.7 pmol/mg,min in the negative control siRNA transfected cells without LPS, negative control siRNA transfected cells with LPS, TLR4 siRNA transfected cells without LPS and TLR4 siRNA transfected cells with LPS, respectively. Results for glucose uptake are expressed as the mean ± SEM of data obtained from 4 subjects. Other values are the mean ± SD of triplicate determinations. Similar experiments were repeated 4 times using cells isolated from different subjects, and representative results are shown. *P<0.05; #P<0.05 compared to basal.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 40 references

Cited by

See all 215

Metadata

Authors
Liang, H., Hussey, S. E., Sanchez-Avila, A., Tantiwong, P., & Musi, N.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Musi, Nicolas
Venue
PLoS ONE
Published
2013-05-21
Volume
8
Issue
5
Pages
e63983
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2048244595
Cited by
215
References
40
Citations by year
2026: 22 · 2025: 12 · 2024: 21 · 2023: 22 · 2022: 19 · 2021: 18 · 2020: 20 · 2019: 14 · 2018: 12 · 2017: 17 · 2016: 9 · 2015: 15 · 2014: 11 · 2013: 3
FWCI
9.23
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • American Diabetes Association
  • National Institutes of Health (UL1TR001120, 8ul1tr000149-05)
  • University of Texas Health Science Center at San Antonio
  • National Institute of Diabetes and Digestive and Kidney Diseases (F32DK095565, R01DK089229, R01DK080157, R01-DK80157)
  • National Center for Advancing Translational Sciences (UL1-TR000149, TR000149)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
lipopolysaccharide, endotoxemia, insulin resistance, skeletal muscle, TLR4, TAK-242, inflammation, glucose metabolism, IRS-1, Akt, AS160, JNK phosphorylation, MCP-1, interleukin-6, LPS-binding protein, obesity, type 2 diabetes, insulin sensitivity
MeSH terms
Lipopolysaccharide-Binding Protein, Acute-Phase Proteins, Adult, Carrier Proteins, Humans, Inflammation, Insulin, Insulin Resistance, Lipopolysaccharides, Membrane Glycoproteins, Middle Aged, Solubility, Sulfonamides, Signal Transduction, Muscle, Skeletal, Muscle Fibers, Skeletal, Lipopolysaccharide Receptors, Gene Silencing, Toll-Like Receptor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle. https://app.cochat.ai/papers/10.1371/journal.pone.0063983
The paper
Liang, H., Hussey, S. E., Sanchez-Avila, A., Tantiwong, P., & Musi, N. (2013). Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle. PLoS ONE. https://doi.org/10.1371/journal.pone.0063983

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.